Back to School: How biopharma can reboot drug development. Access exclusive analysis here

U.S. IPO valuations

U.S. IPO valuations

Company Date Pre-$ Raised Post-$ Status
Acusphere (ACUS) 10/8/03 $147.3 $52.5 $199.8 Ph III
Advancis (AVNC) 10/17/03 $166.9 $60.0 $226.9 Mkt (drug)
CancerVax (CNVX) 10/29/03 $248.4 $72.0 $320.4 Ph

Read the full 320 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE